<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJNeph</journal-id><journal-title-group><journal-title>Open Journal of Nephrology</journal-title></journal-title-group><issn pub-type="epub">2164-2842</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojneph.2022.123027</article-id><article-id pub-id-type="publisher-id">OJNeph-119499</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Frequently Missed, Never Dismissed: Anticoagulant-Related Nephropathy&lt;br/&gt;—Case Presentation and Review of the Literature
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Awad</surname><given-names>Magbri</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bhushan</surname><given-names>Keshani</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pablo</surname><given-names>Abrego Hernandez</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Marshfield Medical Center, Weston, WI, USA</addr-line></aff><pub-date pub-type="epub"><day>28</day><month>07</month><year>2022</year></pub-date><volume>12</volume><issue>03</issue><fpage>262</fpage><lpage>266</lpage><history><date date-type="received"><day>12,</day>	<month>July</month>	<year>2022</year></date><date date-type="rev-recd"><day>26,</day>	<month>August</month>	<year>2022</year>	</date><date date-type="accepted"><day>29,</day>	<month>August</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  We reported here a case of anticoagulant-related nephropathy (ARN) in an elderly patient with background history of chronic kidney disease (CKD-stage 4, with an estimated glomerular filtration rate (eGFR) of &lt;24 ml/min). He presented with an acute kidney injury on background of chronic kidney disease (AKI/CKD) with eGFR of 9 ml/min and serum creatinine of 6.0 mg/dl.
 
</p></abstract><kwd-group><kwd>Acute Kidney Injury</kwd><kwd> Anticoagulant-Related Nephropathy</kwd><kwd> Warfarin-Related Nephropathy</kwd><kwd> Corticosteroids</kwd><kwd> eGFR</kwd><kwd> Chronic Kidney Disease</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Anticoagulant-related nephropathy (ARN), also known as Warfarin-related Nephropathy (WRN) is an acute kidney injury which may be caused by excessive anticoagulation with warfarin or other anticoagulants [<xref ref-type="bibr" rid="scirp.119499-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.119499-ref2">2</xref>] . ARN has been associated with irreversible kidney injury with increased morbidity and mortality. The term anticoagulant-related nephropathy is more inclusive than warfarin-related nephropathy (WRN), because other anticoagulant can incite and cause the acute kidney injury.</p><p>The patient had gross hematuria at the time of presentation to the hospital. His bassline serum creatinine was 2.6 mg/dl with eGFR of 24 ml/min. There was no evidence of pre-renal or post-renal causes to account for his acute kidney dysfunction.</p></sec><sec id="s2"><title>2. Case History</title><p>An 81-year-old Caucasian male, nursing home resident. He has history of quadriplegia, chronic kidney disease stage-4 with an estimated GFR of 24 ml/min, hypertension, hyperuricemia, atrial fibrillation on warfarin 5 mg per day. He is morbidly obese with lower extremities chronic lymphedema.</p><p>He is on regular follow-up with his cardiologist with stable INR. This time he is admitted to the hospital with low grade fever and altered mental status. He was diagnosed with pneumonia.</p><p>His lab work-up in the emergency department (ED) is shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>On physical examination: The patient is encephalopathic, obese and with significant shortness of breath. He is placed on bilevel positive pressure ventilation (BIPAP) to help in the acute decompensation of cardio-respiratory status. Cardiovascular examination revealed atrial fibrillation with rapid ventricular rate. There is no murmur or rubs. Lung examinations revealed that the patient is using the accessory muscles of respiration with increased work of breathing. Auscultation of the lungs showed widespread crackles in both lung fields. Abdomen is distended with no rebound tenderness. Foley catheter was in place with gross hematuria in the urine bag. Lower extremities showed bilateral 2 - 3+ pitting edema with breakdown of the skin with blisters.</p><p>Management consisted of intra-venous isotonic fluid resuscitation with broad spectrum antibiotics.</p><p>His hospital course showed some improvement in physical examination as well as biochemically in the in the BUN and creatinine, 79 and 5.3 mg/dl by the 2<sup>nd</sup> hospital day. His INR had decreased to 1.8 with stopping of the warfarin and vitamin K supplementation.</p><p>Non-enhanced CT scan of the abdomen revealed normal sized kidneys with no evidence of obstruction. On the fourth hospital day his kidney function stabilized with BUN and creatinine of 74 and 5.0 mg/dl and urine output of 600 ml/day.</p><p>Despite fluid resuscitation and conservative management no further improvement in kidney function had occurred. The decision was made following a long discussion with him and his family to start renal replacement therapy by the 5<sup>th</sup> hospital days.</p></sec><sec id="s3"><title>3. Discussion</title><p>The diagnosis of ARN should be entertained in any patient with AKI in the setting</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Shows some of his biochemical data</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Character</th><th align="center" valign="middle" >value</th></tr></thead><tr><td align="center" valign="middle" >INR Serum creatinine BUN Total CO<sub>2</sub> Albumen Total protein Alkaline phosphatase eGFR</td><td align="center" valign="middle" >9.3 6.0 mg/dl 90 mg/dl 17 mEq/L 2.9 g/L 6.4 g/L 121 units 9 ml/min</td></tr></tbody></table></table-wrap><p>of excessive anticoagulation and hematuria. The definitive diagnosis is made by kidney biopsy which is not always done because of the risks of bleeding and or thromboembolism if the anticoagulant had to stop for renal biopsy.</p><p>It is estimated that the incidence of AKI in patients on anticoagulant was 20.5% overall and 33% in patients with a history of chronic kidney disease [<xref ref-type="bibr" rid="scirp.119499-ref3">3</xref>] . The strongest risk factor for ARN is an INR of &gt;4 and CKD. Other predictor factors for ARN were age, diabetes mellitus, heart failure, hypertension, and glomerular diseases, particularly the nephrotic syndrome [<xref ref-type="bibr" rid="scirp.119499-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.119499-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.119499-ref6">6</xref>] .</p><p>Kidney biopsy in ARN frequently showed obstruction of renal tubules by RBC casts, and little in the way of inflammation in the distal tubules of the kidneys [<xref ref-type="bibr" rid="scirp.119499-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.119499-ref8">8</xref>] . Disruption of the glomerular filtration barriers is thought to be the main pathophysiological events. The mechanism is poorly understood.</p><p>The glomeruli showed little or no abnormalities by immunofluorescence, light, or electron microscopy.</p><p>The pathogenesis and diagnosis of ARN is based on the histological analysis of kidney tissues obtained by kidney biopsy and the extrapolation of information obtained from the experimental animal models for ARN [<xref ref-type="bibr" rid="scirp.119499-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.119499-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.119499-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.119499-ref10">10</xref>] . The most prominent features on biopsy are;</p><p>● Glomerular hemorrhage</p><p>● Obstruction of the renal tubules by red blood cells casts</p><p>● Tubular epithelial cell injury</p><p>Glomerular hemorrhage results from over coagulation with the formation of tubular obstruction by RBC casts are the main and consistent histological features of ARN [<xref ref-type="bibr" rid="scirp.119499-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.119499-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.119499-ref11">11</xref>] . However, the number of obstructed tubules by RBC casts observed on microscopy do not appear sufficient to explain the decrease in GFR. Only small percentage of tubules are completely obstructed by RBC casts on histology [<xref ref-type="bibr" rid="scirp.119499-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.119499-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.119499-ref11">11</xref>] , which can be explained by misrepresentation of the obstructed tubules on histology because of the small sample size that is usually examined under the microscopy. This can be a plausible explanation of the discrepancy between the clinical and the histological pictures.</p><p>Brodsky et al. published a data on 9 patients with WRN. A total of 3 patients had complete kidney recovery and 6 patients had partial/to no kidney recovery. All the 3 patients who recovered kidney function had normal estimated glomerular filtration rate (eGFR) before the incident and no history of CKD [<xref ref-type="bibr" rid="scirp.119499-ref7">7</xref>] .</p><p>The management of ARN in patients requiring anticoagulation poses dilemma. Alternative to warfarin like dabigatran (direct thrombin inhibitor) and rivaroxaban, apixaban, and edoxaban (direct-activated factor X inhibitors) are being used but are also plagued with the occurrences of ARN [<xref ref-type="bibr" rid="scirp.119499-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.119499-ref13">13</xref>] . A reduced kidney function with an eGFR of &lt;30 ml/min poses the greatest risk for ARN [<xref ref-type="bibr" rid="scirp.119499-ref14">14</xref>] .</p><p>The role of steroids is not clear in ARN. The anti-inflammatory effects of steroids may be useful in mitigating the interstitial fibrosis sometimes induced in ARN. Temporary interruption of anticoagulation may ameliorate glomerular bleeding with stabilization of the renal function [<xref ref-type="bibr" rid="scirp.119499-ref15">15</xref>] . However, patient with significant reduction in kidney function frequently end-up on renal replacement therapy [<xref ref-type="bibr" rid="scirp.119499-ref16">16</xref>] .</p><p>Back to our patient, despite a conservative management over an extended period of time, the decision was made to place him on renal replacement therapy, in the form of hemodialysis, for fluid and electrolyte management. He remained dialysis dependent.</p></sec><sec id="s4"><title>4. Conclusion</title><p>Patients who develop AKI in the setting of chronic anticoagulation therapy with high INR, a presumptive diagnosis of ARN should be entertained as a possibility if other causes of AKI have been excluded. Renal biopsy is the definitive way to diagnose ARN but it is not always practical or possible to carry out. The most important measure to prevent ARN is proper adjustment of anticoagulation dose, especially in patients with CKD who are more susceptible to the development of ARN.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Magbri, A., Keshani, B. and Hernandez, P.A. (2022) Frequently Missed, Never Dismissed: Anticoagulant-Related Nephropathy. Open Journal of Nephrology, 12, 262-266. https://doi.org/10.4236/ojneph.2022.123027</p></sec></body><back><ref-list><title>References</title><ref id="scirp.119499-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Ryan, M., Ware, K., Qamri, Z., et al. (2014) Warfarin-Related Nephropathy Is the Tip of the Iceberg: Direct Thrombin Inhibitor Dabigatran Induces Glomerular Hemorrhage with Acute Kidney Injury in Rats. Nephrology Dialysis Transplantation, 29, 2228-2234. https://doi.org/10.1093/ndt/gft380</mixed-citation></ref><ref id="scirp.119499-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Wheeler, D.S., Giugliano, R.P. and Rangaswami, J. (2016) Anticoagulation-Related Nephropathy. Journal of Thrombosis and Haemostasis, 14, 461-467. https://doi.org/10.1111/jth.13229</mixed-citation></ref><ref id="scirp.119499-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Golla, A., Goli, R., Nagalla, V.K., et al. (2018) Warfarin-Related Nephropathy. Indian Journal of Nephrology, 28, 378-381.</mixed-citation></ref><ref id="scirp.119499-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Kabir, A., Nadasdy, T., Nadasty, G. and Herbert, L.A. (2004) An Unusual Cause of Gross Hematuria and Transient ARF in an SLE Patient with Warfarin Coagulopathy. American Journal of Kidney Diseases, 43, 757-760. https://doi.org/10.1053/j.ajkd.2003.08.050</mixed-citation></ref><ref id="scirp.119499-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Abt, A.B., Carrol, L. and Mohler, J.H. (2000) Thin Basement Membrane Disease and Acute Renal Failure Secondary to Gross Hematuria and Tubular Necrosis. American Journal of Kidney Diseases, 35, 533-536. https://doi.org/10.1016/S0272-6386(00)70209-5</mixed-citation></ref><ref id="scirp.119499-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Brodsky, S.V., Nadasdy, T., Rovin, B.H., et al. (2011) Warfarin-Related Nephropathy Occurs in Patients with and without Chronic Kidney Disease and Is Associated with an Increased Mortality Rate. Kidney International, 80, 181-189. https://doi.org/10.1038/ki.2011.44</mixed-citation></ref><ref id="scirp.119499-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Brodsky, S.V., Collins, M., Park, E., et al. (2010) Warfarin Therapy That Results in an International Normalization Ratio above the Therapeutic Range Is Associated with Accelerated Progression of Chronic Kidney Disease. Nephron Clinical Practice, 115, c142-c146. https://doi.org/10.1159/000312877</mixed-citation></ref><ref id="scirp.119499-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">An, J.N., Ahn, S.Y., Yoon, C.H., et al. (2013) The Occurrence of Warfarin-Related Nephropathy and Effects on Renal and Patient Outcomes in Korean Patients. PLOS ONE, 8, e57661. https://doi.org/10.1371/journal.pone.0057661</mixed-citation></ref><ref id="scirp.119499-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Brodsky, S.V., Satoskar, A., Chen, J., et al. (2009) Acute Kidney Injury during Warfarin Therapy Associated with Obstructive Tubular Red Blood Cell Casts: A Report of 9 Cases. American Journal of Kidney Diseases, 54, 1121-1126. https://doi.org/10.1053/j.ajkd.2009.04.024</mixed-citation></ref><ref id="scirp.119499-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ozcan, A., Ware, K., Calomeni, E., et al. (2012) 5/6 Nephrectomy as a Validated Rat Model Mimicking Human Warfarin-Related Nephropathy. American Journal of Nephrology, 35, 356-364. https://doi.org/10.1159/000337918</mixed-citation></ref><ref id="scirp.119499-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Ware, K., Brodsky, P., Satoskar, A.A., et al. (2011) Warfarin-Related Nephropathy Modeled by Nephron Reduction and Excessive Anticoagulation. Journal of the American Society of Nephrology, 22, 1856-1862. https://doi.org/10.1681/ASN.2010101110</mixed-citation></ref><ref id="scirp.119499-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Schutzer, K.M., Svensson, M.K., Zetterstrand, S., et al. (2010) Reversible Elevations of Serum Creatinine Levels but No Effect on Glomerular Filtration during Treatment with the Direct Thrombin Inhibitor AZD0837. European Journal of Clinical Pharmacology, 66, 903-910. https://doi.org/10.1007/s00228-010-0849-7</mixed-citation></ref><ref id="scirp.119499-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Bohm, M., Ezekowitz, M.D., Connolly, S.J., et al. (2015) Changes in Renal Function in Patients with Atrial Fibrillation: An Analysis from the RE-LY Trial. Journal of the American College of Cardiology, 65, 2481-2493. https://doi.org/10.1016/j.jacc.2015.03.577</mixed-citation></ref><ref id="scirp.119499-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Yao, X., Tangri, N., Gersh, B.J., et al. (2017) Renal Outcomes in Anticoagulated Patients with Atrial Fibrillation. Journal of the American College of Cardiology, 70, 2621-2632. https://doi.org/10.1016/j.jacc.2017.09.1087</mixed-citation></ref><ref id="scirp.119499-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Chan, Y.H., Yeh, Y.H., See, L.C., et al. (2016) Acute Kidney Injury in Asians with Atrial Fibrillation Treated with Dabigatran or Warfarin. Journal of the American College of Cardiology, 68, 2272-2283. https://doi.org/10.1016/j.jacc.2016.08.063</mixed-citation></ref><ref id="scirp.119499-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ware, K., Brodsky, P., Satoskar, A.A., Nadasdy, T., Nadasdy, G., Wu, H., et al. (2011) Warfarin-Related Nephropathy Modeled by Nephrone Reduction and Excessive Anticoagulation. Journal of the American Society of Nephrology, 22, 1856-1862. https://doi.org/10.1681/ASN.2010101110</mixed-citation></ref></ref-list></back></article>